0001735933-20-000003.txt : 20200309 0001735933-20-000003.hdr.sgml : 20200309 20200309144852 ACCESSION NUMBER: 0001735933-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200309 DATE AS OF CHANGE: 20200309 EFFECTIVENESS DATE: 20200309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redpin Therapeutics, Inc. CENTRAL INDEX KEY: 0001735933 IRS NUMBER: 815353627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362277 FILM NUMBER: 20697675 BUSINESS ADDRESS: STREET 1: 1392 MADISON AVENUE STREET 2: SUITE 125 CITY: NEW YORK STATE: NY ZIP: 10029 BUSINESS PHONE: 9179719655 MAIL ADDRESS: STREET 1: 1392 MADISON AVENUE STREET 2: SUITE 125 CITY: NEW YORK STATE: NY ZIP: 10029 D 1 primary_doc.xml X0708 D LIVE 0001735933 Redpin Therapeutics, Inc. 1392 MADISON AVENUE SUITE 125 NEW YORK NY NEW YORK 10029 9179719655 DELAWARE None None Corporation true 2017 Elma Hawkins 1392 Madison Avenue Suite 125 New York NY NEW YORK 10029 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-02-25 false true false 0 30000000 7787462 22212538 false 8 0 0 0 false Redpin Therapeutics, Inc. Elma Hawkins Elma Hawkins President 2020-03-09